PROCYTE CORP /WA/
10-Q, EX-27, 2000-11-08
PHARMACEUTICAL PREPARATIONS
Previous: PROCYTE CORP /WA/, 10-Q, 2000-11-08
Next: CRAFTMADE INTERNATIONAL INC, 10-Q, 2000-11-08



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       3,144,132
<SECURITIES>                                         0
<RECEIVABLES>                                1,152,099
<ALLOWANCES>                                  (65,421)
<INVENTORY>                                  2,165,180
<CURRENT-ASSETS>                             6,492,955
<PP&E>                                       6,148,746
<DEPRECIATION>                               3,725,289
<TOTAL-ASSETS>                              12,477,511
<CURRENT-LIABILITIES>                          920,726
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    85,093,164
<OTHER-SE>                                (73,686,569)
<TOTAL-LIABILITY-AND-EQUITY>                12,477,511
<SALES>                                      3,650,299
<TOTAL-REVENUES>                             4,813,634
<CGS>                                        1,073,403
<TOTAL-COSTS>                                5,472,817
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,585,177)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,585,177)
<EPS-BASIC>                                     (0.10)
<EPS-DILUTED>                                   (0.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission